Medicover: Interim Report January-March 2018

STOCKHOLM, April 26, 2018 /PRNewswire/ --

• Revenue increased by 14.1% to €161.9m (€141.9m). Organic revenue grew by 13.3%.
• Operating profit amounted to €8.1m (€6.8m), representing an operating margin of 5.0% (4.8%).
• Net profit amounted to €9.4m (€4.4m), which represents a net profit margin of 5.8% (3.1%).
• Cash flow from operating activities amounted to €6.6m (€8.8m).
• Basic/diluted earnings per share (EPS) was €0.067 (€0.040).
• EBITDA increased by 13.6% to €15.0m (€13.2m), corresponding to an EBITDA margin of 9.3% (9.3%).

REVENUE AND EARNINGS

[1] For Alternative Performance Meassure definitions and reconciliations, refer to note 6 

This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 (CET) on 26 April 2018. This interim report and other information about Medicover, is available at medicover.com.

For further information, please contact:
Paula Treutiger
Corporate Communications & Investor Relations
Director  
Phone: +46-73-66-6599
Mail: paula.treutiger@medicover.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/medicover/r/interim-report-january-march-2018,c2505870

The following files are available for download: